Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Seeking Alpha

02:03 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "Seeking Alpha" found in our extensive news archives from over 250 global news sources.

More Information about Seeking Alpha on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seeking Alpha for you to read. Along with our medical data and news we also list Seeking Alpha Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seeking Alpha Companies for you to search.

Showing News Articles 1–25 of 6,000+ from Seeking Alpha

Saturday 20th October 2018

Cancer Research Highlight: Merck Takes Its Big Swing At Kidney Cancer

FDA Issues Warning To MannKind After Report Of Misbranding

Friday 19th October 2018

T2 Biosystems: Buying The Dip

Fonar: Buy In Slowly, But Buy In

Proteostasis Therapeutics Delivered 400% Stock Returns

The Cisco Of Pot Makes Another Key Purchase

Orchard Therapeutics Begins U.S. IPO Process In Volatile Market

Hoth Therapeutics Files For $10.5 Million IPO

Trevena Is Toast

SI-BONE: Fairly Valued Medtech After Opening Day Jump

Assembly Biosciences: A Horseman Of The HBV Core-Pocalypse?

Viking Therapeutics: A Valuation

Buy Johnson & Johnson For Dividend Growth And Steady Defensive Earnings: Third-Quarter Report

Thursday 18th October 2018

Intuitive Surgical, Inc. (ISRG) CEO Gary Guthart on Q3 2018 Results - Earnings Call Transcript

What's Wrong With Exelixis?

Biotech Analysis Central Pharma News: Regeneron's Results, Bristol-Myers' Failure, Novartis' FDA Rejection

Biotech Analysis Central Pharma News: Regeneron's Results, BMY's Failure, Novartis' FDA Rejection

Novartis' (NVS) CEO Vas Narasimhan on Q3 2018 Results - Earnings Call Transcript

Luminex Corporation (LMNX) CEO Homi Shamir on Acquisition of MilliporeSigma's Flow Cytometry Portfolio Call - Transcript

Canopy Growth, Constellation Brands, And Irrational Exuberance

Gamida IPO: Phase 3 Of Development

AcelRx Will Overcome Its Recent Stock Woes

GW Pharma Pipeline Will Add To Bottom Line And Stock Price

Axonics Modulation Seeks $86 Million In U.S. IPO

2 PARP Concerns On The Move


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks